CFG
PTCT icon

Citizens Financial Group’s PTC Therapeutics PTCT Stock Holding History

Citizens Financial Group’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-750
Closed -$38K – 757
2020
Q2 		$38K Hold
750
– – ﹤0.01% 520
2020
Q1 		$33K Buy
+750
New +$37.8K ﹤0.01% 504

Other funds holding PTCT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Citizens Financial Group's PTCT Position: Q3 2020 in Review

Citizens Financial Group sold out of PTC Therapeutics (PTCT) in Q3 2020, closing a stake of 750 shares — an estimated $38K sold.

Citizens Financial Group first reported a position in PTCT in Q1 2020 and held it in 2 quarters. The position peaked at $38K in Q2 2020. 196 funds tracked by Wall St. Rank hold PTCT as of Q3 2020.

  • Citizens Financial Group reported no remaining PTC Therapeutics position as of Q3 2020 after selling out during the quarter.
  • Citizens Financial Group sold 750 PTC Therapeutics shares in Q3 2020, an estimated $38K.
  • Citizens Financial Group first reported a position in PTC Therapeutics in Q1 2020 and held it in 2 quarters.
  • Citizens Financial Group's PTC Therapeutics position peaked at $38K in Q2 2020.
  • 196 funds tracked by Wall St. Rank held PTC Therapeutics as of Q3 2020.

Based on Citizens Financial Group's 13F filing for Q3 2020, filed 12 Nov 2020.